Periodontal disease and FAM20A mutations.

Kantaputra PN*, Bongkochwilawan C, Lubinsky M, Pata S, Kaewgahya M, Tong HJ, Ketudat Cairns JR, Guven Y, Chaisrisookumporn N.

J Hum Genet 2017;62(7):679-86.

Plasma prefractionation methods for proteomic analysis and perspectives in clinical applications.

Chutipongtanate S*, Chatchen S, Svasti J.

Proteomics Clin Appl 2017;11(7-8):1600135.

Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.

Verathamjamras C, Weeraphan C, Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Diskul-Na-Ayudthaya P, Mingkwan K, Luevisadpaibul V, Chutipongtanate S, Champattanachai V, Svasti J, Srisomsap C*.

Int J Oncol 2017;51(1):269-80.

Inhibitory effects of ATP and adenosine on cholangiocarcinoma cell proliferation and motility.
Lertsuwan, J., &Ruchirawat, M. (2017).
Anticancer Research, 37(7), 3553-3561.

The combination of arginine deprivation and 5-fluorouracil improves therapeutic efficacy in argininosuccinatesynthetase negative hepatocellular carcinoma.
Thongkum, A., Wu, C., Li, Y. Y., Wangpaichitr, M., Navasumrit, P., Parnlob, V., Savaraj, N. (2017).
International Journal of Molecular Sciences, 18(6).